Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus: The New Jersey 725

Archives of Ophthalmology

Volumn 125, Issue 8, 2007, Pages 1061-1067

  Roy, Monique S ^a   Skurnick, Joan ^b  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AFRICA; ARTICLE; BLINDNESS; BLOOD EXAMINATION; BLOOD PRESSURE MEASUREMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIPLOPIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROTEINURIA; RETINOPATHY; RISK FACTOR; URINALYSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AFRICAN AMERICANS; AGE FACTORS; BLINDNESS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEW JERSEY; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TIME FACTORS; VISUAL ACUITY;

EID: 34547889035     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.8.1061     Document Type: Article

References (27)

1. Klein R, Klein BE. Vision disorders in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:293-338. NIH publication 95-1468.
2. Kahn H, Moorhead H. Statistics on Blindness in the Model Reporting Area, 1969-1970. Washington, DC: US Government Printing Office; 1973. NIH publication 73-427.
3. Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol. 2000;118(1):97-104.
4. Klein R, Klein B, Moss S. Visual impairment in diabetes. Ophthalmology. 1984;91(1):1-9.
5. Moss SE, Klein R, Klein BE. The incidence of vision loss in a diabetic population. Ophthalmology. 1988;95(10):1340-1348.
6. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101(6):1061-1070.
7. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998-1003.
8. Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol. 2006;124(9):1297-1306.
9. Early Treatment of Diabetic Retinopathy Study (ETDRS). Manual of Operations. Baltimore, MD: ETDRS Coordinating Center, Dept of Epidemiology and Preventive Medicine, University of Maryland; 1985.
10. Diabetic Retinopathy Study Research Group. Report number 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21(1)(pt 2):210-226.
11. Canner PL, Borhani NO, Oberman A, et al. The Hypertension Prevention Trial. Am J Epidemiol. 1991;134(4):379-392.
12. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. Ophthalmology. 1991;98(5)(suppl):786-806.
13. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS Report Number 12. Ophthalmology. 1991;98(5)(suppl):823-833.
14. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103(12):1796-1806.
15. Goldthorpe J, Hope K. The Social Grading of Occupations: A New Approach and Scale. New York, NY: Oxford University Press; 1974:134-143.
16. Caird F. Diabetic retinopathy as a cause of visual impairment. In: Diabetes and the Eye. Oxford, England: Blackwell; 1968:41-46.
17. Nielsen NV. Diabetic retinopathy 1: the course of retinopathy in insulin-treated diabetics. Acta Ophthalmol (Copenh). 1984;62(2):256-265.
18. Sjolie AK, Green A. Blindness in insulin-treated diabetic patients with age at onset <30 years. J Chronic Dis. 1987;40(3):215-220.
19. Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med. 1993;10(6):555-559.
20. Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998;39(2):233-252.
21. Rand LI, Prud'homme GJ, Ederer F, Canner PL. Factors influencing the development of visual loss in advanced diabetic retinopathy: Diabetic Retinopathy Study (DRS) report No. 10. Invest Ophthalmol Vis Sci. 1985;26(7):983-991.
22. Kaufman SC, Ferris FL III, Seigel DG, Davis MD, DeMets DL. Factors associated with visual outcome after photocoagulation for diabetic retinopathy: Diabetic Retinopathy Study Report #13. Invest Ophthalmol Vis Sci. 1989;30(1):23-28.
23. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Ophthalmology. 1981;88(7):583-600.
24. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
25. Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725, II: risk factors. Arch Ophthalmol. 2000;118(1):105-115.
26. Roy MS. Proteinuria in African Americans with type 1 diabetes. J Diabetes Complications. 2004;18(1):69-77.
27. Roy M, Rendas-Baum R, Skurnick J. Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabet Med. 2006;23(6):698-706.